Ministry of Education, China
7
1
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools
Role: collaborator
Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study
Role: collaborator
Beijing Vascular Disease Patients Evaluation STudy
Role: collaborator
Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2
Role: collaborator
Fangshan / Family-based Ischemic Stroke Study In China
Role: collaborator
Corticosteroids in the Treatment of Tuberculous Pleurisy
Role: collaborator
Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients
Role: collaborator
All 7 trials loaded